Impact of the National Health Insurance Coverage Policy on the Utilisation and Accessibility of Innovative Anti-cancer Medicines in China: An Interrupted Time-Series Study
Objective: The study aimed to evaluate the impact of the National Health Insurance Coverage (NHIC) policy on the utilisation and accessibility of innovative anti-cancer medicines in Nanjing, China.Methods: We used the adjusted World Health Organisation and Health Action International methodology to...
Saved in:
Main Authors: | Wenqing Fang (Author), Xinglu Xu (Author), Yulei Zhu (Author), Huizhen Dai (Author), Linlin Shang (Author), Xin Li (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Trends in accessibility of negotiated targeted anti-cancer medicines in Nanjing, China: An interrupted time series analysis
by: Yanyan Liu, et al.
Published: (2022) -
Impact of medical insurance access negotiation on the utilization of innovative anticancer drugs in China: an interrupted time series analysis
by: Cui Li, et al.
Published: (2024) -
Impact of national drug price negotiation policy on the accessibility and utilization of PCSK9 inhibitors in China: an interrupted time series analysis
by: Lingli Zhang, et al.
Published: (2024) -
The impact of the national volume-based procurement policy on the use of policy-related drugs in Nanjing: an interrupted time-series analysis
by: Xiao Wang, et al.
Published: (2023) -
Trends and Patterns of Antibiotics Use in China's Urban Tertiary Hospitals, 2016-19
by: Yulei Zhu, et al.
Published: (2021)